홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

4-Piperidinemethanol → (3-(4-((4-(Hydroxymethyl)piperidin-1-yl)methyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone

HRID 1035262
인쇄

반응식

HRID 1035262 반응식
[NH:1]1[CH2:6][CH2:5][CH:4]([CH2:7][OH:8])[CH2:3][CH2:2]1.[CH3:9][O:10][C:11]1[CH:16]=[CH:15][C:14]([C:17]2[O:21][C:20]([C:22]([N:24]3[CH2:27][CH:26]([O:28][C:29]4[CH:36]=[CH:35][C:32]([CH:33]=O)=[CH:31][CH:30]=4)[CH2:25]3)=[O:23])=[N:19][N:18]=2)=[CH:13][CH:12]=1.[Na].C([O-])(O)=O.[Na+]>ClCCl>[OH:8][CH2:7][CH:4]1[CH2:5][CH2:6][N:1]([CH2:33][C:32]2[CH:31]=[CH:30][C:29]([O:28][CH:26]3[CH2:27][N:24]([C:22]([C:20]4[O:21][C:17]([C:14]5[CH:15]=[CH:16][C:11]([O:10][CH3:9])=[CH:12][CH:13]=5)=[N:18][N:19]=4)=[O:23])[CH2:25]3)=[CH:36][CH:35]=2)[CH2:2][CH2:3]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 4207714-PiperidinemethanolHCID 516892Sodium BicarbonateHCID 5360545SodiumHCID 580430894-(1-(5-(4-Methoxyphenyl)-1,3,4-oxadiazole-2-carbonyl)azetidin-3-yloxy)benzaldehyde

생성물 1

HCID 56599191(3-(4-((4-(Hydroxymethyl)piperidin-1-yl)methyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone

시약·촉매·용매 1

HCID 6344Dichloromethane용매2회

실험 절차

Piperidin-4-ylmethanol (0.04 g, 0.35 mmol) was dissolved in dichloromethane (2 mL) and TEA (0.052 ml, 0.38 mmol) was added. Intermediate 55A (0.11 g, 0.29 mmol) was added followed by addition of sodium triacetoxyhydroborate (0.123 g, 0.58 mmol). The mixture was stirred at RT overnight. Dichloromethane (10 mL) and NaHCO3 (sat. 2 mL) were added and the mixture was filtered through a phase separator and the solvent was removed by evaporation. The product was purified by preparative reverse-phase HPLC at pH 10 to give 81 mg (58%). 1H NMR (600 MHz, DMSO) δ 1.05-1.17 (m, 2H), 1.28-1.39 (m, 1H), 1.57-1.66 (m, 2H), 1.82-1.92 (m, 2H), 2.75-2.84 (m, 2H), 3.19-3.27 (m, 3H), 3.83-3.92 (m, 3H), 4.06-4.13 (m, 1H), 4.37-4.45 (m, 1H), 4.5-4.67 (m, 2H), 5.04-5.19 (m, 2H), 6.85 (d, 2H), 7.16-7.27 (m, 4H), 8-8.05 (m, 2H), MS (APCI+) m/z 479 [M+H]+, LC-purity: 99%.

후처리

  1. filtrationthe mixture was filtered through a phase separator
  2. customthe solvent was removed by evaporation
  3. customThe product was purified by preparative reverse-phase HPLC at pH 10
  4. customto give 81 mg (58%)

출처 및 근거

ORD 기록
ord-f18a935cee03424991a0a7b73763abd2
출처 데이터셋
uspto-grants-2013_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08546375B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트